Redcare Pharmacy NV - Income Statement (TTM)

Redcare Pharmacy NV
IT ˙ BIT ˙ NL0012044747
€108.20 0.00 (0.00%)
2025-09-05
SHARE PRICE
Income Statement (TTM)

Redcare Pharmacy NV Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 895 968 1,020 1,038 1,037 1,060 1,081 1,118 1,165 1,204 1,272 1,404 1,595 1,799 1,987 2,128 2,227 2,371 2,528 2,676
Change (%) 8.14 5.38 1.74 -0.08 2.25 1.95 3.41 4.17 3.42 5.59 10.43 13.60 12.76 10.46 7.09 4.66 6.46 6.63 5.88
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 700 749 778 787 779 794 806 827 853 873 918 1,024 1,185 1,358 1,519 1,635 1,710 1,825 1,945 2,056
Change (%) 6.92 3.89 1.14 -0.99 1.90 1.59 2.54 3.17 2.32 5.17 11.54 15.77 14.63 11.81 7.65 4.60 6.71 6.61 5.70
% of Revenue 78.21 77.32 76.23 75.79 75.10 74.84 74.57 73.94 73.23 72.45 72.17 72.89 74.28 75.52 76.44 76.84 76.80 76.98 76.97 76.84
Gross Operating Profit 195 220 242 251 258 267 275 291 312 332 354 381 410 440 468 493 517 546 582 620
Change (%) 12.52 10.45 3.64 2.77 3.30 3.04 5.95 7.03 6.43 6.67 7.57 7.77 7.33 6.31 5.25 4.85 5.64 6.67 6.46
% of Revenue 21.79 22.68 23.77 24.21 24.90 25.16 25.43 26.06 26.77 27.55 27.83 27.11 25.72 24.48 23.56 23.16 23.20 23.02 23.03 23.16
SG&A 194 214 238 256 277 299 320 359 368 379 393 392 419 444 473 501 532 581 621 655
Change (%) 10.51 11.39 7.32 8.09 8.19 7.08 12.09 2.55 2.96 3.70 -0.40 6.90 6.18 6.41 5.90 6.16 9.27 6.83 5.56
% of Revenue 21.64 22.11 23.37 24.65 26.67 28.22 29.64 32.12 31.62 31.48 30.92 27.89 26.24 24.71 23.81 23.54 23.88 24.51 24.56 24.49
R&D
Change (%)
% of Revenue
OpEx 894 963 1,016 1,042 1,055 1,093 1,126 1,186 1,221 1,252 1,311 1,415 1,603 1,803 1,991 2,135 2,241 2,406 2,566 2,711
Change (%) 7.70 5.56 2.59 1.24 3.54 3.09 5.26 2.97 2.52 4.73 7.96 13.31 12.42 10.48 7.23 4.96 7.33 6.66 5.67
% of Revenue 99.83 99.43 99.60 100.43 101.75 103.04 104.19 106.05 104.83 103.92 103.08 100.76 100.51 100.21 100.22 100.36 100.65 101.47 101.50 101.31
Operating Income 1 6 4 -4 -18 -32 -45 -68 -56 -47 -39 -11 -8 -4 -4 -8 -15 -35 -38 -35
Change (%) 271.46 -25.72 -208.19 307.28 77.30 40.53 49.34 -16.85 -16.08 -17.17 -72.55 -23.97 -53.55 17.51 71.95 89.61 140.48 8.68 -7.98
% of Revenue 0.17 0.57 0.40 -0.43 -1.75 -3.04 -4.19 -6.05 -4.83 -3.92 -3.08 -0.76 -0.51 -0.21 -0.22 -0.36 -0.65 -1.47 -1.50 -1.31
Interest Expense -12 -11 -9 -9 -9 -9 -9 -11 -11 -9 -8 -8 -8 -8 -8 -8 -9 -8 -8 -15
Change (%) -13.73 -20.84 9.03 -4.11 -3.81 5.35 17.00 8.00 -25.42 -0.22 -10.90 -0.22 6.03 4.46 1.57 3.62 -11.58 7.74 82.70
% of Revenue -1.39 -1.11 -0.83 -0.89 -0.86 -0.81 -0.83 -0.94 -0.98 -0.71 -0.67 -0.54 -0.47 -0.44 -0.42 -0.40 -0.39 -0.33 -0.33 -0.57
Net Income -15 -17 -18 -29 -39 -74 -91 -105 -110 -78 -65 -45 -16 -12 -10 -9 -25 -45 -48 -35
Change (%) 9.47 4.96 62.55 36.35 90.15 23.11 14.95 5.13 -29.64 -16.37 -31.21 -63.67 -25.80 -20.07 -3.02 163.20 85.08 6.63 -28.10
% of Revenue -1.71 -1.73 -1.73 -2.76 -3.76 -7.00 -8.45 -9.39 -9.48 -6.45 -5.11 -3.18 -1.02 -0.67 -0.48 -0.44 -1.10 -1.92 -1.92 -1.30

Source: Capital IQ

Other Listings
US:SHPPF
GB:0RJT
DE:RDC €72.70
GB:RDCD
AT:SHOP
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista